Variables Associated with HbA1c Improvement during CGM Therapy in Persons with T1D Treated with Multiple Daily Insulin Injections (MDI)

被引：0
|
作者：
Ahlen, Elsa
Polonsky, William H.
Heise, Tim
Bolinder, Jan
Hirsch, Irl B.
Wedel, Hans
Hellman, Jarl
Olafsdottir, Arndis
Frid, Anders
Lind, Marcus
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
935-P
引用
收藏
页码：A241 / A241
页数：1
相关论文
共 50 条
  • [41] IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS
    Vigersky, Robert A.
    Huang, Suiying
    Cordero, Toni L.
    Shin, John
    Lee, Scott W.
    Chhabra, Harmeet
    Kaufman, Francine R.
    Cohen, Ohad
    ENDOCRINE PRACTICE, 2018, 24 (05) : 446 - 452
  • [42] Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI
    Lind, Marcus
    Olafsdottir, Arndis F.
    Hirsch, Irl B.
    Bolinder, Jan
    Dahlqvist, Sofia
    Pivodic, Aldina
    Hellman, Jarl
    Wijkman, Magnus
    Schwarcz, Erik
    Albrektsson, Henrik
    Heise, Tim
    Polonsky, William
    DIABETES CARE, 2021, 44 (01) : 141 - 149
  • [43] Increased HbA1c Variability May Shorten Time to Microalbuminuria Development in Type 1 Diabetes (T1D)
    Clements, Mark A.
    Wu, Mengdi
    Foster, Nicole C.
    Laffel, Lori M.
    Shah, Viral N.
    Vendrame, Francesco
    Kingman, Ryan S.
    Alonso, Guy T.
    Carlson, Anders
    Desalvo, Daniel J.
    Buckingham, Bruce A.
    Sherr, Jennifer
    Benjamin, Robert
    Eyth, Emily
    Dubose, Stephanie
    DIABETES, 2018, 67
  • [44] Frequency of Self-Monitoring of Blood Glucose (SMBG) Is Associated with Hemoglobin A1c (HbA1c) Levels in Youth with Type 1 Diabetes (T1D) Enrolled in the T1D Exchange Clinic Registry
    Miller, Kellee M.
    Hirsch, Irl B.
    Beck, Roy W.
    DIABETES, 2011, 60 : A340 - A340
  • [45] HbA1c and Mortality in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study of Type 1 Diabetes (T1D)
    Miller, Rachel G.
    Orchard, Trevor J.
    DIABETES, 2013, 62 : A418 - A418
  • [46] TXNIP DNA Methylation (DNAme) and Long-Term HbA1c in Type 1 Diabetes (T1D)
    Miller, Rachel G.
    Mychaleckyj, Josyf
    Onengut-Gumuscu, Suna
    Orchard, Trevor J.
    Costacou, Tina
    DIABETES, 2022, 71
  • [47] Insulin Patch Pump Therapy vs. Multiple Daily Injections (MDI) in 2,729 Youth with Type 1 Diabetes (T1D): Data from the German-Austrian DPV-Registry
    Danne, Thomas
    Heidtmann, Bettina
    Rami-Merhar, Birgit
    Ziegler, Ralph
    Holl, Reinhard W.
    DIABETES, 2016, 65 : A340 - A340
  • [48] A pilot interventional study to evaluate the impact of cholecalciferol treatment on HbA1c in type 1 diabetes (T1D)
    Perchard, R.
    Magee, L.
    Whatmore, A.
    Ivison, F.
    Murray, P.
    Stevens, A.
    Mughal, M. Z.
    Ehtisham, S.
    Campbell, J.
    Ainsworth, S.
    Marshall, M.
    Bone, M.
    Doughty, I.
    Clayton, P. E.
    ENDOCRINE CONNECTIONS, 2017, 6 (04): : 225 - 231
  • [49] Glucose-Independent Racial Disparity in HbA1c Is Present at Onset of Type 1 Diabetes (T1D)
    Alaqeel, Aqeel
    Chalew, Stuart
    DIABETES, 2019, 68
  • [50] CGM USE WITH OR WITHOUT REMOTE MONITORING DURING PREGNANCIES ASSOCIATED WITH TYPE 1 DIABETES (T1D)
    Polsky, S.
    Garcetti, R.
    Pyle, L.
    Joshee, P.
    Snell-Bergeon, J.
    Demmitt, J.
    Garg, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A102 - A103
12345